Julius Clemens Heinrich Wilming

Julius Clemens Heinrich Wilming

Auto-generated profile, based on publicly available information

Julius Clemens Heinrich Wilming

Institute for Synthetic Biomedicine, Helmholtz Munich, Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Nature Methods
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
JGJulian Geilenkeuser
Julian Geilenkeuser
SWStephanie Victoria Wendel
Stephanie Victoria Wendel
JWJulius Clemens Heinrich Wilming
Julius Clemens Heinrich Wilming
NANiklas Armbrust
Niklas Armbrust
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Prime editing (PE) is a powerful gene-editing technique based on targeted gRNA-templated reverse transcription and integration of the de novo synthesized single-stranded DNA. To circumvent one of the main bottlenecks of the method, the competition of the reverse-transcribed 3′ flap with the original 5′ flap DNA, we generated an enhanced fluorescence-activated cell sorting reporter cell line to develop an exonuclease-enhanced PE strategy (‘Exo-PE’) composed of an improved PE complex and an aptamer-recruited DNA-exonuclease to remove the 5′ original DNA flap. Exo-PE achieved better overall editing efficacy than the reference PE2 strategy for insertions ≥30 base pairs in several endogenous loci and cell lines while maintaining the high editing precision of PE2. By enabling the precise incorporation of larger insertions, Exo-PE complements the growing palette of different PE tools and spurs additional refinements of the PE machinery.